Similar articles

• [Therapeutic achlorhydria: for which diseases, when and for how long?].

  Koop H, Arnold R. Koop H, et al. Dtsch Med Wochenschr. 1988 Mar 31;113(13):516-8. doi: 10.1055/s-2008-1067675. Dtsch Med Wochenschr. 1988. PMID: 2894969 Clinical Trial. German. No abstract available.
• [Strong inhibition of gastric acid secretion: when is it justifiable?].

  Dobrilla G, Amplaz S, Benvenuti S, Bertozzo A. Dobrilla G, et al. G Clin Med. 1990 Aug-Sep;71(8-9):521-6. G Clin Med. 1990. PMID: 1980653 Clinical Trial. Italian. No abstract available.
• [Omeprazole in the therapy of acid-induced diseases].

  Simon B, Dammann HG, Müller P. Simon B, et al. Z Gastroenterol. 1987 Aug;25 Suppl 3:146-51. Z Gastroenterol. 1987. PMID: 2889299 Clinical Trial. German.
• [Indications and use of omeprazole in esophago-gastro-duodenal diseases].

  Martín de Argila C, Boixeda de Miquel D, Moreira Vicente V, García Plaza A. Martín de Argila C, et al. Rev Clin Esp. 1999 Nov;199(11):729-39. Rev Clin Esp. 1999. PMID: 10638238 Review. Spanish. No abstract available.
• Clinical utility and safety of omeprazole.

  Walan A. Walan A. Methods Find Exp Clin Pharmacol. 1989;11 Suppl 1:107-11. Methods Find Exp Clin Pharmacol. 1989. PMID: 2657279 Review.